RainDance Technologies Investor
RainDance Technologies is making complex genetics simple. The company’s ultra-sensitive genomic tools enable better research of novel non-invasive Fluid Biopsy™ applications that should result in more accurate, reliable, cost-effective and early detection of cancer, inherited and infectious diseases. Major research institutions and laboratories around the world rely on RainDance systems’ performance. Based in Billerica, Massachusetts, the company supports customers using RainDrop Digital PCR and ThunderStorm Targeted Next-Generation Sequencing Systems through its international sales and service operations as well as a global network of distributors and commercial service providers.
Technology:
N/A
Industry:
Preventive Medicine
Headquarters:
Billerica, Massachusetts, United States
Founded Date:
2004
Employees Number:
51-100
Funding Status:
M&A
Investor Type:
N/A
Investment Stage:
N/A
Number Of Exits:
N/A
Register and Claim Ownership